 prosthet valv children adolesc purpos paper short- long-term result prosthet valv replac children period april children year underw replac aortic valv replac mitral valv replac multipl valv replac ninety-four percent lesion rheumat origin congenit infecti valv mechan valv heterograft latter mitral posit patient surgic mortal rate aortic valv mitral valv multipl valv replac five-year actuari surviv aortic valv replac mitral replac multipl valv replac major event reoper death progress myocardi failur death sudden unexpect death thromboembol complic death subacut bacteri endocard death transfus patient five-year complication-fre actuari surviv rate aortic valv replac mitral replac multipl valv replac respect five-year complication-fre surviv rate signific morbid mortal rate valv replac effort nativ valv plastic repar procedur prosthet replac mitral valv data heterograft children year age heterograft children year age expect valv surviv compar mechan valv complic anticoagul therapi drug satisfactori patient aortic valv replac patient mitral replac warfarin therapi patient multipl valv replac risk thromboembol complic